Inhibition of phosphoinositide 3-kinase-beta

Details for Australian Patent Application No. 2003260916 (hide)

Owner AstraZeneca AB

Inventors Saylik, Dilek; Anderson, Karen; Kenche, Vijaya; Schoenwaelder, Simone; Abbott, Belinda; Thompson, Philip; Robertson, Alan D.; Goncalves, Isaac; Prabaharan, Hishani; Jackson, Shaun P.; Nesbitt, Warwick

Agent Davies Collison Cave

Pub. Number AU-B-2003260916

PCT Number PCT/IB03/04177

PCT Pub. Number WO2004/016607

Priority 60/403,639 16.08.02 US; 60/428,283 22.11.02 US

Filing date 18 August 2003

Wipo publication date 3 March 2004

Acceptance publication date 27 November 2008

International Classifications

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/5365 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

20 November 2003 Complete Application Filed

  Priority application(s): 60/403,639 16.08.02 US; 60/428,283 22.11.02 US

22 April 2004 Application Open to Public Inspection

  Published as AU-B-2003260916

14 April 2005 Amendment Made

  The nature of the amendment is: Amend the invention title to read Inhibition of phosphoinositide 3-kinase-beta 2003260985 SK Chemicals Co., Ltd. The nature of the amendment is: Amend the name of the applicant to SK Chemicals Co., Ltd.

2 August 2007 Assignment before Grant

  Kinacia Pty Ltd The application has been assigned to AstraZeneca AB

27 November 2008 Application Accepted

  Published as AU-B-2003260916

26 March 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003260917-METHOD FOR ROBUST ASYMMETRIC MODULATION SPATIAL MARKING WITH SPATIAL SUB-SAMPLING

2003260915-LOW MODULUS SUBSTRATE FOR FLEXIBLE FLAT PANEL DISPLAY